Back to search
FDAFDA · Food and drugs·Recall number D-0559-2016

Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, MFG: Mutual Pharm. Co. Inc., Philadelphia, PA 19124, NDC 43063-509-01

Published January 6, 2016 · Recall initiated: July 10, 2015

Summary

FDA records drug Class II recall D-0559-2016, published January 6, 2016 and initiated July 10, 2015. Recalling firm: PD-Rx Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 9 bottles; Lot: Lot# B14D26, Exp 02/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PD-Rx Pharmaceuticals, Inc.
Distributor
Alabama
Lot
Lot# B14D26, Exp 02/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, MFG: Mutual Pharm. Co. Inc., Philadelphia, PA 19124, NDC 43063-509-01 recalled?

Yes. FDA published recall D-0559-2016 on January 6, 2016. Reported hazard: cGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail